Tech Anatomy

Dans cet épisode, on démonte ensemble certaines des idées reçues les plus courantes sur l’intelligence artificielle. Alors que le Sommet pour l’Action sur l’IA se tient à Paris, c’est le moment idéal pour clarifier le vrai fonctionnement de ces technologies et éviter les malentendus.

Au programme :

• L’IA pense-t-elle comme un humain ? 🤖

• Réseaux de neurones vs cerveau humain : quelles différences ?

• Comment l’IA interprète-t-elle les images ? 🖼️

• L’IA est-elle impartiale parce qu’elle repose sur des maths ?

• Plus de données = meilleure IA ? Pas si simple…

Et en bonus, on aborde une idée reçue fréquente : toutes les IA sont-elles les mêmes ?

En comprenant mieux comment fonctionne l’IA, on peut mieux l’utiliser et éviter les pièges des mythes et fausses croyances. Alors, prêts à déconstruire les idées reçues ?

Credits :
Production : MedShake Studio
Host : Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

Dans cet épisode, nous explorons un sujet de premier plan : la place des patients dans le développement des intelligences artificielles en santé. Le Cercle P, un groupe de réflexion fondé par Pfizer, vient de publier un position paper appelant les décideurs et acteurs du secteur à intégrer pleinement les patients dans cette transformation technologique.

Au programme :

• IA et parcours de soins : quels bénéfices perçus par les patients ?

• Transparence et confiance : pourquoi 80 % des patients souhaitent être impliqués ?

• Craintes et opportunités : comment éviter la déshumanisation des soins ?

• Les prochaines étapes pour une IA éthique et efficace en santé

📌 Le position paper est disponible dès maintenant ici : https://www.pfizer.fr/actualites/nos-engagements/ia-en-sante-la-participation-des-patients-un-facteur-cle-de-son-succes

Credits :
Production : MedShake Studio
Host : Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode, we explore a fascinating and slightly mind-boggling question: Can artificial intelligence predict scientific results more accurately than human experts? According to a study published in Nature Human Behavior by researchers from University College London, the answer is a resounding yes.

Topics Covered:

• The BrainBench Benchmark: How researchers tested human experts and AI on predicting scientific outcomes.

• AI vs. Human Performance: BrainGPT achieved an 81% accuracy rate, outperforming neuroscientists at 63%.

• The Power of AI in Research: How AI can analyze vast amounts of data, identify patterns, and enhance experimental planning.

• Implications for Healthcare & Science: AI’s potential in drug discovery, interdisciplinary research, and reducing cognitive biases.

• Challenges & Ethical Concerns: The risk of over-reliance on AI, the importance of human intuition, and the need for explainable AI decisions.

Could AI revolutionize scientific research, or are there risks we need to consider? Tune in to find out!

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode we dive into a surprising discovery: People resist AI and digital health solutions not just because of privacy concerns—but due to deep emotional barriers.

A recent study from the University of Copenhagen found that surveillance anxiety, delegation anxiety, and trust issues play a significant role in AI hesitancy. Even when AI can save lives, many patients and caregivers feel uneasy about constant monitoring and the potential loss of human decision-making in healthcare.

Topics Covered:

• Why privacy concerns are not the main reason people resist AI in healthcare

• How emotions like surveillance and delegation anxiety shape AI hesitancy

• The importance of trust, control, and human connection in AI adoption

• Strategies for making AI more transparent and patient-friendly

If AI is to be widely adopted, healthcare organizations must address these emotional barriers—not just security fears. Tune in to explore how shifting the narrative can help AI become a trusted healthcare ally.

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode, we explore DeepSeek, a groundbreaking Chinese AI startup that’s making waves with its cost-effective and high-performing models. Known for triggering shockwaves in global financial markets and challenging the status quo of tech giants, DeepSeek’s approach has profound implications for the future of AI in healthcare.

Topics Covered:

• How DeepSeek's cost-efficiency redefines AI accessibility

• The impact of open-source AI models on healthcare innovation

• Ethical and security considerations of using AI developed under different geopolitical contexts

• Implications of DeepSeek's rise on global tech leadership and healthcare priorities

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

What if your next therapy session took place in a calming digital world, guided by an AI-powered avatar? In this episode, weexplore a groundbreaking innovation that combines virtual reality (VR) and artificial intelligence (AI) to transform mental health care.

With a friendly avatar like “Xaia,” patients can experience private, personalized therapy sessions without the barriers of cost, stigma, or geographical limitations.

Topics Covered:

• How VR and AI are being used to deliver therapy

• The role of motivational interviewing and cognitive behavioral therapy in virtual care

• Case study: How virtual therapy is helping tackle alcohol addiction and associated health issues

• Why participants feel more comfortable opening up to AI avatars

• Future possibilities: Hybrid approaches that integrate VR therapy with traditional mental health care

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

The Future of AI-Enabled Health (AI-generated summary)

In this episode, we dive into the findings of the World Economic Forum’s report, The Future of AI-Driven Healthcare: Charting the Path Forward, developed in collaboration with Boston Consulting Group. This report, released in January 2025, explores the transformative potential of artificial intelligence in the healthcare sector and outlines strategies for overcoming the challenges of adoption at scale.

Topics Covered:

• The transformative potential of AI in healthcare: From improving diagnostics and treatment personalization to advancing drug discovery and optimizing healthcare operations.

• Barriers to adoption: Understanding why healthcare lags behind other industries in digital maturity and the challenges posed by structural constraints, regulatory complexities, and public mistrust.

• Future visions of AI in healthcare: Hypothetical scenarios including predictive wellness care, universal AI-powered doctors, and AI-driven operational excellence.

• Key strategies for successful AI implementation: Collaboration between public and private sectors, prioritizing digital public infrastructure, and fostering public trust through ethical practices.

• Equity and inclusion in AI healthcare initiatives: Ensuring that AI tools bridge gaps in access to quality care and prioritize underrepresented populations.

• The critical role of public–private partnerships (PPPs): Demonstrating AI’s scalable value and supporting sustainable innovation.

This episode underscores the urgent need for collaboration, transparency, and a shared vision to unlock AI’s full potential in healthcare. Tune in to explore how ethical, strategic approaches can revolutionize healthcare delivery and outcomes globally.

Full report available here: https://reports.weforum.org/docs/WEF_The_Future_of_AI_Enabled_Health_2025.pdf

This episode was crafted using AI, delivering the key takeaways from this important update in a concise, educational, and accessible format—perfect for staying informed on the go.

Hosted on Ausha. See ausha.co/privacy-policy for more information.

What if AI could go beyond writing emails to managing your day, coordinating projects, or even personalizing medical updates—all without constant human involvement? Welcome to the world of AI agents, digital teammates designed to work autonomously.

In this episode, we break down how AI agents are redefining the boundaries of artificial intelligence. Unlike traditional AI tools like chatbots or GPTs that rely on human direction, AI agents act independently to achieve goals, save time, and create hyper-personalized solutions.

Topics Covered:

• What are AI agents, and how do they differ from traditional AI tools?

• How autonomy transforms AI into a proactive collaborator

• Use cases for AI agents in healthcare, including personalized updates for oncology teams and doctors

• The future of AI agents: Tools like Claude Computer Use and OpenAI's Operator

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

What Do Scientists Really Think About AI Chatbots?

In this episode, Anca dives into a fascinating study recently published in The Lancet Digital Health, which surveyed over 2,400 researchers from 90+ countries to understand their perspectives on AI chatbots in the scientific process. Are tools like ChatGPT and Google Bard transforming research, or are they just another tech trend?

Topics Covered:

• How researchers are using AI chatbots for tasks like manuscript editing, translation, and workflow automation

• Barriers to adoption: concerns about transparency, accuracy, and data privacy

• The lack of institutional training and policies around AI tools

• The growing interest in AI training and the future role of chatbots in research

Credits:
Production: MedShake Studio
Host: Anca Petre

Hosted on Ausha. See ausha.co/privacy-policy for more information.

Takeaways from the FDA's Guidance on using AI to support regulatory decision-making for drug and biological products (AI-generated summary of the document)

In this episode, we unpack the FDA's draft guidance on using artificial intelligence (AI) to support regulatory decision-making for drug and biological products. This guidance outlines a comprehensive framework for assessing the credibility of AI models, detailing essential steps like defining the context of use, evaluating model risk, and maintaining credibility across the product lifecycle. The document highlights the importance of transparency, data quality, and risk-based approaches to ensure that AI-driven insights meet the rigorous standards required for regulatory approval.

Whether you're in the pharmaceutical or biotech sectors, this episode is a must-listen for understanding how AI can accelerate innovation while maintaining compliance with regulatory requirements.

This AI-generated episode is designed to deliver key insights from complex industry updates in a fast, educational, and accessible format—helping you stay informed and ahead of the curve.

Full guidance available here: https://www.fda.gov/media/184830/download

This episode was crafted using AI, delivering the key takeaways from this important update in a concise, educational, and accessible format—perfect for staying informed on the go.

Hosted on Ausha. See ausha.co/privacy-policy for more information.